Please login to the form below

Not currently logged in
Email:
Password:

Chiltern promotes Richard Pilnik to chairman

He replaces Nick Thornton in the lead role

Chiltern Richard PilnikLondon and North Carolina-based clinical research organisation Chiltern has promoted Richard Pilnik to become its new chairman, succeeding Nick Thornton.

Pilnik became a member of the board of directors in 2015 bringing considerable industry experience across Asia, Europe, Latin America and the US to the firm.

Prior to joining Chiltern, Pilnik served as executive vice president at Quintiles and president of its Commercial Solutions division from 2009 until 2014.

He also brings leadership experience from Eli Lilly, which he joined in 1983 and subsequently held a number of senior positions including president for Europe, Middle East, Africa and CIS, and group vice president and chief marketing officer.

Jim Esinhart, chief executive officer of Chiltern, said: “On behalf of Chiltern's senior executive team and staff, as well as the investors and board of directors, I look forward to continuing to work with Rich in his new position as chairman.

“I would also like to thank Nick Thornton for his exceptional contribution to Chiltern over the past 10 years.”

9th June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To transform lives through communication that changes behaviour and improves health outcomes....

Latest intelligence

How nature can help you manage the pressures of agency life
Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....